Latest Health & Nutrition News and Videos
Standard disease frameworks are meeting their ma
Five-year renewal backs new drug discovery proje
A fresh analyst upgrade and encouraging clinical
Haut.
Alterity Therapeutics received official End-of-Ph
Catalent and Nanoscope Therapeutics expanded thei
RoslinCT and BlueRock Therapeutics have entered a
Aptorum Group Limited and DiamiR Biosciences anno
The seventh Longevity Investors Conference bring
Year-long study shows people with mild Alzheimer
Company to spotlight clinical progress on immune
Theriva Biologics announced that the Spanish Agen
Helix announced a multi-year agreement with Astra
Insilico has initiated a Phase III clinical trial
Annovis Bio Inc.
Kailera reported positive topline results from tw
As South Korea’s peptide market surges, partne
BioAge has begun iPhase 2 QUELL-CV trial, testin
Insilico’s rentosertib enters late-stage testi
Eyepoint Pharmaceuticals will participate in the
Alterity Therapeutics has received official U.S.
NeuroSense announced that it will participate in
Cumulus Neuroscience announced a collaboration wi
Alzheon will present nine posters at the alzheime
Alzheon will present nine posters at the alzheime
Forget one-size-fits-all wellness.
Newly validated pluripotent-like platform enters
As conversation expands beyond amyloid, upcoming
A cosmetic laser may be doing something science
Biogen is diversifying its portfolio across neuro
Leerink initiated coverage of Altimmune, Inc.
AlzeCure has entered an out-licensing and collabo
NKGen Biotech will present its lead investigation
United Therapeutics has acquired Thymmune Therape
Sky Labs presented its ring-type cuffless blood p
Partnership reflects a bigger shift: medical wea
New findings suggest investigational therapy may
New peptide reviews aim to bring structure and t
Company introduces BASE, its lowest-priced membe
Biomarker results suggest PrimeC may be acting o
UCL and Eisai have signed a new agreement extendi
NkGen Biotech will present Troculeucel, its cryop
Elixirgen Therapeutics has expanded its rare dise
NorthStrive Biosciences, a subsidiary of PMGC Hol
MED-EL has acquired two gene therapy programs fro
Insilico Medicine announced a strategic collabora
FDA RDEP eligibility for REP-0003 in HoFH streng
Vasily Yurenkov, founder and CEO of Greener Relo
Prema Cognition and Phoenix Community launch one
A new in vivo program could help bring regenerat